Increased 8-isoprostane, a marker of oxidative stress in exhaled breath condensate in subjects with asbestos exposure

Industrial Health

Volumn 46, Issue 5, 2008, Pages 484-489

  Pelclová, Daniela ^a   Fenclová, Zdenka ^a   Kačer, Petr ^b   Kuzma, Marek ^c   Navrátil, Tomáš ^d   Lebedová, Jindřiška ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^d J HEYROVSKÝ INSTITUTE OF PHYSICAL CHEMISTRY   (Czech Republic)

Author keywords

1 antitrypsin; 1 microglobulin; 8 isoprostane; Asbestos; Asbestosis; Breath condensate; Cotinine; Pleural hyalinosis; Rheumatoid factor

Indexed keywords

8 ISOPROSTANE; ASBESTOS; BIOLOGICAL MARKER;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ASBESTOSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSPRAY; FEMALE; HUMAN; INDUSTRIAL WORKER; LIQUID CHROMATOGRAPHY; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PLEURA PLAQUE;

AGED; AGED, 80 AND OVER; ASBESTOS; ASBESTOSIS; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; DINOPROST; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PROGNOSIS; RISK ASSESSMENT;

EID: 54449087661     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.46.484     Document Type: Article

References (21)

1. Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT (2003) Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Rad Biol Med 34, 117-1129.
2. Kopnin PB, Kravchenko IV, Furalyov VA, Pylev LN, Kopnin BP (2004) Cell type-specific effects of asbestos on intracellular ROS levels, DNA oxidation and G1 cell cycle checkpoint. Oncogene 23, 8834-40.
3. Dopp E, Yadav S, Ansari FA, Bhattacharya K, von Reclinghausen U, Rauen U, Rodelsperger K, Shokouhi B, Geh S, Rahman Q (2005) ROS-mediated genotoxicity of asbestos-cement in mammalian lung cells in vitro. Part Fibre Toxicol 2, 2-9.
4. Morrow JD (2006) The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr Pharm Des 12, 895-902.
5. Barnes PJ (2005) Exhaled breath condensate: a new approach to monitoring lung inflammation. In: New perspectives in monitoring lung inflammation. Analysis of exhaled breath condensate. Montuschi P (Ed.), 1-9, CRC Press, Boca Raton.
6. Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini D, Piacentini G, Zacchellon F, Zanconnato S (2003) Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 58, 505-9.
7. Psathakis K, Mermigkis D, Papatheodorou G, Loukides S, Panagou P, Polychronopoulos V, Siafakas NM, Bouros D (2006) Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Invest 36, 362-7.
8. Pelclová D, Fenclová Z, Kaěr P, Kuzma M, Lebedová J, Klusáčková P, Balíková M, Navrátil T (2005) Exhaled breath condensate in asbestos exposure. CHEST 128 (Suppl), 345-6.
9. Lehtonen H, Oksa P, Lehtimäki L, Sepponen A, Nieminen R, Kankaanranta H, Saarelainen S, Järvenpää R, Uitti J, Moilanen E (2007) Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax 62, 602-7.
10. Heinrich-Ramm R, Wegner R, Garde AH, Baur X (2002) Cotinine excretion (tobacco smoke biomarker) of smokers and non-smokers: comparison of GC/ MS and RIA results. Int J Hyg Environ Health 205, 493-9.
11. Hagemeyer O, Otten H, Kraus T (2006) Asbestos consumption, asbestos exposure and asbestos-related occupational diseases in Germany. Int Arch Occup Environ Health 79, 613-20.
12. Guidelines for the use of ILO international classification of radiographs of pneumoconiosis 22, 1980. Revised edition. Geneva, ILO 1980.
13. Syslová K, Kaěr P. Kuzma M, Lebedová J, Klusáčková P, Fenclová Z, Pelclov ́D (2008) Determination of 8-iso-prostaglandin F (2alpha) in exhaled breath condensate using combination of immunoseparation with LC-ESI-MS. J Chromatogr B Analyt Technol Biomed Life Sci 867, 8-14.
14. Mulgrew AT, Taggart CC, Lawless MW (2004) Z alphal-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest 125, 195 2-7.
15. Pelclová D, Bartũňková J, Fenclová Z, Lebedová J, Hladíková M, Benáková H (2003) Asbestos exposure and antineutrophil cytoplasmic Antibody (ANCA) positivity. Arch Environ Health 58, 662-8.
16. 1-Microglobulin is found both in blood and in most tissues. J Histochem Cytochem 46, 887-94.
17. Patrignani P, Tacconelli S (2005) Isoprostanes and other markers of peroxidation in atherosclerosis. Biomarkers 10 (Suppl 1), 24-9.
18. Horváth, I, Hunt J, Barnes PJ. ATS/ERS Task Force on Exhaled Breath Condensate (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26, 523-48.
19. Rosias PP, Robroeks CMN, Niemarkt HJ, Kester AD, Vernooy JH, Suykerbuyk J, Teunissen J, Heynens J, Hendriks HJ, Höbsis Q, Dompeling E (2006) Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J 28, 1036-41.
20. Montuschi P (2007) Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Therap Adv Respir Dis 1, 5-23.
21. Pelclová D, Fenclová Z, Kaěr P, Kuzma M, Navrátil T, Lebedová J, Klusáǩová P (2007) Arachidonic acid derivatives in the exhaled breath condensate in pneumoconioses and their correlation with individual factors. Chem Listy 101, s144-6.